BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 29211715)

  • 1. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.
    Skrott Z; Mistrik M; Andersen KK; Friis S; Majera D; Gursky J; Ozdian T; Bartkova J; Turi Z; Moudry P; Kraus M; Michalova M; Vaclavkova J; Dzubak P; Vrobel I; Pouckova P; Sedlacek J; Miklovicova A; Kutt A; Li J; Mattova J; Driessen C; Dou QP; Olsen J; Hajduch M; Cvek B; Deshaies RJ; Bartek J
    Nature; 2017 Dec; 552(7684):194-199. PubMed ID: 29211715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway.
    Majera D; Skrott Z; Chroma K; Merchut-Maya JM; Mistrik M; Bartek J
    Cells; 2020 Feb; 9(2):. PubMed ID: 32085572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-alcohol abuse drug disulfiram inhibits human PHGDH via disruption of its active tetrameric form through a specific cysteine oxidation.
    Spillier Q; Vertommen D; Ravez S; Marteau R; Thémans Q; Corbet C; Feron O; Wouters J; Frédérick R
    Sci Rep; 2019 Mar; 9(1):4737. PubMed ID: 30894617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.
    Skrott Z; Majera D; Gursky J; Buchtova T; Hajduch M; Mistrik M; Bartek J
    Oncogene; 2019 Oct; 38(40):6711-6722. PubMed ID: 31391554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation.
    Meier S; Cantilena S; Niklison Chirou MV; Anderson J; Hargrave D; Salomoni P; de Boer J; Michod D
    Cell Death Dis; 2021 Aug; 12(8):785. PubMed ID: 34381018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion.
    Beaudry A; Jacques-Ricard S; Darracq A; Sgarioto N; Garcia A; García TR; Lemieux W; Béland K; Haddad E; Cordeiro P; Duval M; McGraw S; Richer C; Caron M; Marois F; St-Onge P; Sinnett D; Banquy X; Raynal NJ
    Sci Rep; 2023 Sep; 13(1):16443. PubMed ID: 37777587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor?
    Cvek B; Dvorak Z
    Drug Discov Today; 2008 Aug; 13(15-16):716-22. PubMed ID: 18579431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seesaw conformations of Npl4 in the human p97 complex and the inhibitory mechanism of a disulfiram derivative.
    Pan M; Zheng Q; Yu Y; Ai H; Xie Y; Zeng X; Wang C; Liu L; Zhao M
    Nat Commun; 2021 Jan; 12(1):121. PubMed ID: 33402676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacology of disulfiram - an update].
    Mutschler J; Diehl A; Kiefer F
    Fortschr Neurol Psychiatr; 2008 Apr; 76(4):225-31. PubMed ID: 18415930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfiram: an old therapeutic with new applications.
    Barth KS; Malcolm RJ
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):5-12. PubMed ID: 20201810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does disulfiram have a role in alcoholism treatment today? Not to forget about disulfiram's psychological effects.
    Ehrenreich H; Krampe H
    Addiction; 2004 Jan; 99(1):26-7; author reply 27-8. PubMed ID: 14678057
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disulfiram and addiction: reminders and new perspectives of use].
    Charpeaud T; Geneste J; Schmidt J; Llorca PM; Brousse G
    Therapie; 2011; 66(3):273-80. PubMed ID: 21924121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying chronic alcoholism drug disulfiram as a potent DJ-1 inhibitor for cancer therapeutics.
    Wu Q; Zhang M; Wen Y; He P; He Q; Yang B; Jiang L; Yuan M; Cao J
    Eur J Pharmacol; 2022 Jul; 926():175035. PubMed ID: 35605658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
    Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
    Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfiram: a novel repurposed drug for cancer therapy.
    Lu C; Li X; Ren Y; Zhang X
    Cancer Chemother Pharmacol; 2021 Feb; 87(2):159-172. PubMed ID: 33426580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells.
    Loffelmann M; Škrott Z; Majera D; Štarha P; Kryštof V; Mistrík M
    Eur J Med Chem; 2023 Dec; 261():115790. PubMed ID: 37690264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram revisited.
    O'Shea B
    Hosp Med; 2000 Dec; 61(12):849-51. PubMed ID: 11211585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfiram's journey from rubber vulcanization to T-cell activation.
    Dosset M; Zanetti M
    EMBO J; 2022 Aug; 41(16):e111862. PubMed ID: 35848116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism.
    Loo TW; Clarke DM
    J Natl Cancer Inst; 2000 Jun; 92(11):898-902. PubMed ID: 10841824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does disulfiram still have a role in alcoholism treatment?].
    Blanc M; Daeppen JB
    Rev Med Suisse; 2005 Jun; 1(26):1728-30, 1732-3. PubMed ID: 16117046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.